Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA.

Abstract:

:The prevalence of anti-hepatitis C virus (HCV) enzyme immunoassay (EIA)-positive in 167,511 Australian volunteer blood donors from Adelaide, Melbourne, Perth, and Sydney was 0.78%. One thousand two-hundred and eighteen EIA-positive serum samples were assessed by supplemental tests including a blocking EIA and two peptide EIAs corresponding to major epitopes of the HCV C-100-3 antigen. Seven hundred and eighteen samples (59%) were negative by supplemental testing; no evidence of reactivity with other HCV gene products or HCV RNA detected by cDNA polymerase chain reaction was found in selected samples from this group. In contrast, of 43 samples randomly selected from 400 samples (32.8%) positive by supplemental testing, 88% were reactive with HCV 33-C or core antigens and 52% contained HCV RNA, suggesting contact with HCV and infectivity of most donors in this group. Most samples equivocal by supplemental testing reacted only with C-100 and not with other HCV antigens when tested by dot immunoblot assay. Only 21% had detectable HCV RNA. The battery of assays used in this study indicated that approximately 32% of HCV EIA repeatably reactive serum samples were serologically related to HCV, corresponding to a 0.25% prevalence of potentially infectious donors.

journal_name

Blood

journal_title

Blood

authors

Allain JP,Coghlan PJ,Kenrick KG,Whitson K,Keller A,Cooper GJ,Vallari DS,Delaney SR,Kuhns MC

subject

Has Abstract

pub_date

1991-11-01 00:00:00

pages

2462-8

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

78

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.

    abstract::FLT3 is constitutively activated by internal tandem duplications (ITDs) in the juxtamembrane domain or by activation loop mutations in acute myeloid leukemia (AML). We tested the sensitivity of 8 activation loop mutations to the small molecule FLT3 inhibitor, MLN518. Each FLT3 activation loop mutant, including D835Y, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4446

    authors: Clark JJ,Cools J,Curley DP,Yu JC,Lokker NA,Giese NA,Gilliland DG

    更新日期:2004-11-01 00:00:00

  • Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.

    abstract::Antibody-induced antigenic modulation (AIAM) of CD10 and CD19 was studied on NALM-6, RAJI, and JOK-1 cell lines using fluorescence microscopy (FM), flow cytometry (FCM), and immunoelectron microscopy (IEM). Cross-linking with monoclonal antibodies (MoAbs) induced rapid redistribution of CD10 and CD19 on the cell surfa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pulczynski S,Boesen AM,Jensen OM

    更新日期:1993-03-15 00:00:00

  • Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

    abstract::A polymorphic variant of the phosphatase PTPN22 has been associated with increased risk for multiple autoimmune diseases. The risk allele is thought to function by diminishing antigen-receptor signals responsible for negative selection of autoreactive lymphocytes. We now show that PTPN22 is markedly overexpressed in c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403162

    authors: Negro R,Gobessi S,Longo PG,He Y,Zhang ZY,Laurenti L,Efremov DG

    更新日期:2012-06-28 00:00:00

  • In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.

    abstract::Human hematopoietic stem cells are pluripotent, ie, capable of producing both lymphoid and myeloid progeny, and are therefore used for transplantation and gene therapy. An in vitro culture system was developed to study the multi-lineage developmental potential of a candidate human hematopoietic stem cell population, C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hao QL,Smogorzewska EM,Barsky LW,Crooks GM

    更新日期:1998-06-01 00:00:00

  • JAK2 inhibitors for myeloproliferative neoplasms: what is next?

    abstract::Since its approval in 2011, the Janus kinase 1/2 (JAK1/2) inhibitor ruxolitinib has evolved to become the centerpiece of therapy for myelofibrosis (MF), and its use in patients with hydroxyurea resistant or intolerant polycythemia vera (PV) is steadily increasing. Several other JAK2 inhibitors have entered clinical te...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-04-742288

    authors: Bose P,Verstovsek S

    更新日期:2017-07-13 00:00:00

  • The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.

    abstract::1-deamino-8-d-arginine vasopressin (desmopressin [DDAVP]) is clinically efficacious in patients with mild platelet function disorders but it is not known which mechanisms mediate this effect. Our aim was to evaluate the impact of in vivo DDAVP administration in these patients. We assessed von Willebrand factor (VWF), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-497123

    authors: Colucci G,Stutz M,Rochat S,Conte T,Pavicic M,Reusser M,Giabbani E,Huynh A,Thürlemann C,Keller P,Alberio L

    更新日期:2014-03-20 00:00:00

  • Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.

    abstract::Factor V Leiden (FVL) is associated with venous thrombosis; however, an association between FVL and arterial thrombosis remains controversial. We investigated FVL as a risk factor for myocardial infarction (MI), ischemic stroke (IS), or non-MI ischemic heart disease (non-MI-IHD). The design was 3 case-control studies ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2002-01-0111

    authors: Juul K,Tybjaerg-Hansen A,Steffensen R,Kofoed S,Jensen G,Nordestgaard BG

    更新日期:2002-07-01 00:00:00

  • Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis.

    abstract::Congenital hypothyroidism (CH) is one of the most prevalent endocrine diseases, for which the underlying mechanisms remain unknown; it is often accompanied by anemia and immunodeficiency in patients. Here, we created a severe CH model together with anemia and T lymphopenia to mimic the clinical features of hypothyroid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-05-783043

    authors: Zhang Y,Xue Y,Cao C,Huang J,Hong Q,Hai T,Jia Q,Wang X,Qin G,Yao J,Wang X,Zheng Q,Zhang R,Li Y,Luo A,Zhang N,Shi G,Wang Y,Ying H,Liu Z,Wang H,Meng A,Zhou Q,Wei H,Liu F,Zhao J

    更新日期:2017-11-16 00:00:00

  • Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts.

    abstract::Lipid rafts are sphingolipid- and cholesterol-rich membrane microdomains that are insoluble in nonionic detergents, have a low buoyant density, and preferentially contain lipid-modified proteins, like glycosyl phosphatidylinositol (GPI)-anchored proteins. The lipid rafts were isolated from human erythrocytes and major...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.4.1141

    authors: Salzer U,Prohaska R

    更新日期:2001-02-15 00:00:00

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic regimen, but accelerated platelet generation may reduce the duration of platelet cyclooxygenase-1 (COX-1) inhibition. We performed a multicenter doubl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004596

    authors: Rocca B,Tosetto A,Betti S,Soldati D,Petrucci G,Rossi E,Timillero A,Cavalca V,Porro B,Iurlo A,Cattaneo D,Bucelli C,Dragani A,Di Ianni M,Ranalli P,Palandri F,Vianelli N,Beggiato E,Lanzarone G,Ruggeri M,Carli G,Ell

    更新日期:2020-07-09 00:00:00

  • Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

    abstract::Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARalpha fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guidez F,Ivins S,Zhu J,Söderström M,Waxman S,Zelent A

    更新日期:1998-04-15 00:00:00

  • Serial studies in von Willebrand's disease: variability versus "variants".

    abstract::The variability of laboratory findings in von Willebrand's disease (vWd) was evaluated by performing serial studies of bleeding time (BT), factor VIII coagulant activity (VIII:C), factor-VIII-related antigen (VIIIR:Ag) and ristocetin cofactor (VIIIR:Rcof) in 50 individuals from 25 families with this disorder. The type...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abildgaard CF,Suzuki Z,Harrison J,Jefcoat K,Zimmerman TS

    更新日期:1980-10-01 00:00:00

  • Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors.

    abstract::Thymus atrophy is the most common immunopathology in humans, and its occurrence is hastened by several factors that coalesce in patients receiving chemotherapy and most of all in recipients of hematopoietic cell transplantation. We have shown previously that posthematopoietic cell transplantation thymic function was i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-350553

    authors: Heinonen KM,Vanegas JR,Brochu S,Shan J,Vainio SJ,Perreault C

    更新日期:2011-11-10 00:00:00

  • Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells.

    abstract::Until recently, the identification of cellular factors that govern the developmental program of human stem cells has been difficult due to the absence of repopulation assays that detect human stem cells. The transplantation of human bone marrow (BM) or cord blood (CB) into non-obese diabetic (NOD)/severe-combined immu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kapp U,Bhatia M,Bonnet D,Murdoch B,Dick JE

    更新日期:1998-09-15 00:00:00

  • Evidence that growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells.

    abstract::Donor-matched transplantation of hematopoietic stem cells (HSCs) is widely used to treat hematologic malignancies but is associated with high mortality. The expansion of HSC numbers and their mobilization into the bloodstream could significantly improve therapy. We report here that adult mice conditionally deficient f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-280305

    authors: Khandanpour C,Sharif-Askari E,Vassen L,Gaudreau MC,Zhu J,Paul WE,Okayama T,Kosan C,Möröy T

    更新日期:2010-12-09 00:00:00

  • Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

    abstract::To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty p...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-11-393801

    authors: Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

    更新日期:2012-06-28 00:00:00

  • Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.

    abstract::Investigators in the United Kingdom have shown that hereditary amyloidosis can be misdiagnosed as Ig light-chain (AL) amyloidosis because family history is an ineffective screen, and tissue staining used to type amyloid is unreliable. Misdiagnosis of AL can lead to inappropriate use of chemotherapy and failure to diag...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4148

    authors: Comenzo RL,Zhou P,Fleisher M,Clark B,Teruya-Feldstein J

    更新日期:2006-05-01 00:00:00

  • High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

    abstract::Transforming mutations in NRAS and KRAS are thought to play a causative role in the development of numerous cancers, including myeloid malignancies. Although mutations at amino acids 12, 13, or 61 account for the majority of oncogenic Ras variants, we hypothesized that less frequent mutations at alternate residues may...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-152157

    authors: Tyner JW,Erickson H,Deininger MW,Willis SG,Eide CA,Levine RL,Heinrich MC,Gattermann N,Gilliland DG,Druker BJ,Loriaux MM

    更新日期:2009-02-19 00:00:00

  • Blood tests for the diagnosis of venous and arterial thrombosis.

    abstract::There are many reports in the literature of blood test abnormalities occurring in patients with venous or arterial thrombosis. Most of these have not used acceptable criteria for establishing an association between thrombosis and blood tests and, therefore, their interpretation is questionable. Recently, sensitive and...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Hirsh J

    更新日期:1981-01-01 00:00:00

  • Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling.

    abstract::ELL-12, a liposome formulation of the ether-lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH(3)), is a nonmyelosuppressive antiproliferative agent that is more effective and less toxic than the ether lipid itself in tumor model systems. We found that ELL-12 induced apoptosis in Jurkat, H9, and U-9...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cuvillier O,Mayhew E,Janoff AS,Spiegel S

    更新日期:1999-11-15 00:00:00

  • Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.

    abstract::The tal-1 gene encodes a basic helix-loop-helix (bHLH) transcription factor required for primitive and definitive hematopoiesis. Additionally, ectopic activation of the tal-1 gene during T lymphopoiesis occurs in numerous cases of human T-cell acute lymphoblastic leukemia. With the use of transgenic mice, we show that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.2.491

    authors: Goardon N,Schuh A,Hajar I,Ma X,Jouault H,Dzierzak E,Roméo PH,Maouche-Chrétien L

    更新日期:2002-07-15 00:00:00

  • High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

    abstract::The purpose of this study was to estimate the incidence and to establish which factors were associated with an increased risk of hemorrhagic complications in an historic cohort of 117 consecutive and unselected patients with chronic idiopathic thrombocytopenic purpura (ITP). Sixty-eight patients (58%) underwent medica...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cortelazzo S,Finazzi G,Buelli M,Molteni A,Viero P,Barbui T

    更新日期:1991-01-01 00:00:00

  • Whole genome scanning as a cytogenetic tool in hematologic malignancies.

    abstract::Over the years, methods of cytogenetic analysis evolved and became part of routine laboratory testing, providing valuable diagnostic and prognostic information in hematologic disorders. Karyotypic aberrations contribute to the understanding of the molecular pathogenesis of disease and thereby to rational application o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2008-02-130435

    authors: Maciejewski JP,Mufti GJ

    更新日期:2008-08-15 00:00:00

  • Breaking barriers.

    abstract::It is difficult to imagine a greater challenge to the transplantation of haploidentical cells than thalassemia. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2009-11-254987

    authors: Woolfrey A

    更新日期:2010-02-11 00:00:00

  • Immunologic abnormalities in myelofibrosis with activation of the complement system.

    abstract::Eighteen patients with agnogenic myeloid metaplasia with myelofibrosis were studied for clinical and laboratory evidence of immunologic dysfunction. Clinical findings included the presence of arthritis, vasculitis, and erythema nodosum. Laboratory abnormalities included the presence of circulating immune complexes, an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gordon BR,Coleman M,Kohen P,Day NK

    更新日期:1981-11-01 00:00:00

  • Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasomes, induces apoptosis in multiple myeloma (MM) cells; however, prolonged drug exposure may result in cumulative toxicity and the development of chemoresistance. Here we show that combining PK-11195 (PK), an antagonist to mitochondrial peripheral benzodiazepine rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0547

    authors: Chauhan D,Li G,Podar K,Hideshima T,Mitsiades C,Schlossman R,Munshi N,Richardson P,Cotter FE,Anderson KC

    更新日期:2004-10-15 00:00:00

  • Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.

    abstract::Glutathione-S-transferase (GST)-Grb2 fusion proteins have been used to identify the potential role of Grb2-binding proteins in platelet activation by the platelet low-affinity IgG receptor, Fc gamma RIIA. Two tyrosine phosphoproteins of 38 and 63 kD bind to the SH2 domain of Grb2 following Fc gamma RIIA stimulation of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Robinson A,Gibbins J,Rodríguez-Liñares B,Finan PM,Wilson L,Kellie S,Findell P,Watson SP

    更新日期:1996-07-15 00:00:00

  • Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism.

    abstract::Interleukin-8 (IL-8) is a neutrophil chemotactic and activating cytokine that is produced in response to several stimuli. Because monocytic cells are important producers of IL-8, we investigated whether interferon-gamma (IFN-gamma), a potent inducer of activation and differentiation of mononuclear phagocytes, affected...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bosco MC,Gusella GL,Espinoza-Delgado I,Longo DL,Varesio L

    更新日期:1994-01-15 00:00:00

  • Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.

    abstract::We found an unusual fc gamma receptor IIIa (CD16) phenotype on the natural killer (NK) cells of a 3-year-old boy, who suffered from recurrent viral respiratory tract infections since birth. He also had severe clinical problems after Bacille Calmette-Geérin (BCG) vaccination and following Epstein-Barr virus and Varicel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Vries E,Koene HR,Vossen JM,Gratama JW,von dem Borne AE,Waaijer JL,Haraldsson A,de Haas M,van Tol MJ

    更新日期:1996-10-15 00:00:00

  • How I treat chronic graft-versus-host disease.

    abstract::Allogeneic stem cell transplantation (SCT) is now a commonplace procedure. Clinicians who care for patients with hematologic malignancies and aplastic anemia are almost certain to follow up patients after SCT. This review is intended to help clinicians observe patients for probably the most important late complication...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.v97.5.1196

    authors: Vogelsang GB

    更新日期:2001-03-01 00:00:00